top of page

A2 Milk (ASX: A2M)




Headline numbers


FY20 Guidance:

  • Revenue of NZD $1.7b to $1.75b

  • EBITDA margin of 31-32%: implied EBITDA range of NZD $527m to $560m


Consensus:

  • Revenue of NZD $1.76b

  • EBITDA of NZD $563.6m

  • NPAT of NZD $394.9m


Actual result:

  • in line with what the market was expecting at a headline level



Products and geographical segments



  • growth in all product segments and all geographies

  • main driver of growth: infant formula product segment, increasing 33.8%


Geographical perspective:


USA

  • gaining momentum

  • EBITDA loss due to increase in marketing and distribution spend

  • launched in Canada by a licensing agreement in July 2020 FY


Asia region

  • makes up more than 40% of the group's revenue

  • focused a lot of efforts and marketing spend on this region (particularly around their one brand two label strategy),

  • which led to growing market share in key china-based retail channels (such as mother and baby stores, cross-border e-commerce channels).


Risk of focusing on dominant geographic player:

  • potential new regulation

  • possibility of a comeback in some of their domestic brands

  • geopolitical risk (e.g. barley and beef fiasco between Australia and China)


Cash balance and capital allocation



  • ending cash balance: $854.2 million

  • the stronger cash balance was predominantly driven by the growth in revenue and net profit

  • also smaller contributors such as improvements in working capital

  • due to strong cash flows over the past few years, they've been able to build up a significant cash balance which they can easily deploy for the growth initiatives


Capital allocation framework



  • plan to self-fund all their initiatives by the cash flow that they generate from operations

  • priorities that they intend to focus on are:

  1. growing their core business in existing markets (e.g. recently offered to acquire a majority stake in a NZ business called Mataura Valley Milk - to help scale their infant nutrition business)

  2. expand into new products and geographies and have potential M&A

  3. maintain a level of balance sheet strength

  • only then will A2 consider returning excess cash flow to shareholders = dividend payout is probably not going to happen for awhile


FY21 Outlook



201020

0 comments

Comments


bottom of page